Showing results (141-150 of 293) with videos related to

Sort By:
Pageof 30
Medical and Pediatric Oncology|November 5, 2003
Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experienceBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
EJNMMI Research|March 7, 2018
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinomaJorge A Carrasquillo, Joseph A O'Donoghue, Volkan Beylergil, et al.
Leukemia & Lymphoma|August 10, 2011
Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary diseaseHeather Landau, Neeta Pandit-Taskar, Hani Hassoun, et al.
Cancer|June 15, 2013
Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancerKaren A Autio, Neeta Pandit-Taskar, Jorge A Carrasquillo, et al.
Health Physics|February 25, 2014
Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancerLawrence T Dauer, Matthew J Williamson, John Humm, et al.
EJNMMI Research|May 19, 2015
Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumorsNeeta Pandit-Taskar, Joseph A O'Donoghue, Chaitanya R Divgi, et al.
Clinical Colorectal Cancer|December 28, 2013
Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapyConstantinos T Sofocleous, Alessandra R Garcia, Neeta Pandit-Taskar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2019
Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic CancerChristian Lohrmann, Eileen M O'Reilly, Joseph A O'Donoghue, et al.
JCO Precision Oncology|August 10, 2023
Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in AdultsJessica Stiefel, Brian H Kushner, Stephen S Roberts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 23, 2022
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using <sup>89</sup>Zr-Trastuzumab PET: A Pilot StudyMelissa A Lumish, Steven B Maron, Viktoriya Paroder, et al.
Pageof 30